Wird geladen...
Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
The recent outbreak of Coronavirus disease (COVID-19), first in Eastern Asia and then essentially across the world has been declared a pandemic by the WHO. COVID-19 is caused by a novel virus SARS-CoV2 (2019-nCoV), against which there is currently no vaccine available; and current antiviral therapie...
Gespeichert in:
| Veröffentlicht in: | Life Sci |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7430345/ https://ncbi.nlm.nih.gov/pubmed/32818545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2020.118275 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|